Status:

COMPLETED

Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia

Lead Sponsor:

Prof Kathryn Maitland

Collaborating Sponsors:

Imperial College London

Conditions:

Severe Anaemia

Eligibility:

All Genders

60-12 years

Phase:

PHASE2

Brief Summary

Greater volume of whole blood(30mls/kg compared to 20mls/kg) following standard calculations, given to children with severe anaemia will be beneficial in haematological correction and can be given saf...

Detailed Description

Severe anemia (SA, hemoglobin \<6 g/dl) is a leading cause of pediatric hospital admission in Africa, with significant in-hospital mortality. The underlying etiology is often infectious, but specific ...

Eligibility Criteria

Inclusion

  • Severe anaemia(HB less than 6g/dl)at admission
  • Guardian or parent willing/able to provide consent

Exclusion

  • Malignancy
  • Surgery
  • Acute trauma
  • Severe malnutrition

Key Trial Info

Start Date :

October 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2012

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT01461590

Start Date

October 1 2011

End Date

January 1 2012

Last Update

April 1 2015

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Mbale Regional Referral Hospital

Mbale, Mbale, Uganda

2

Soroti Regional Hospital

Soroti, Soroti, Uganda

Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia | DecenTrialz